Compounds > 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and agmatine

3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid has been researched along with agmatine in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Courteix, C; Eschalier, A; Fialip, J; Hernandez, A; Pélissier, T; Privat, AM	1

Other Studies

1 other study(ies) available for 3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid and agmatine

Article	Year
Agmatine induces antihyperalgesic effects in diabetic rats and a superadditive interaction with R(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid, a N-methyl-D-aspartate-receptor antagonist. The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:3 Topics: Agmatine; Animals; Anticonvulsants; Diabetes Mellitus, Experimental; Drug Interactions; Excitatory Amino Acid Antagonists; Hyperalgesia; Pain; Piperazines; Rats; Receptors, N-Methyl-D-Aspartate; Streptozocin	2007

Article

Year

Agmatine induces antihyperalgesic effects in diabetic rats and a superadditive interaction with R(-)-3-(2-carboxypiperazine-4-yl)-propyl-1-phosphonic acid, a N-methyl-D-aspartate-receptor antagonist.

The Journal of pharmacology and experimental therapeutics, 2007, Volume: 322, Issue:3

Topics: Agmatine; Animals; Anticonvulsants; Diabetes Mellitus, Experimental; Drug Interactions; Excitatory Amino Acid Antagonists; Hyperalgesia; Pain; Piperazines; Rats; Receptors, N-Methyl-D-Aspartate; Streptozocin

2007